Search Results
Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
Search for other papers by Wentao Zhou in
Google Scholar
PubMed
Search for other papers by Tiantao Kuang in
Google Scholar
PubMed
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Wenqi Chen in
Google Scholar
PubMed
Search for other papers by Xuefeng Xu in
Google Scholar
PubMed
Search for other papers by Wenhui Lou in
Google Scholar
PubMed
Search for other papers by Dansong Wang in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasm (pNEN) is a rare malignancy arising from pancreatic islet cells and accounts for 1–2% of all pancreatic tumors ( 1 ). However, with the popularization of abdominal imaging and the promotion of
Search for other papers by Linfei Yang in
Google Scholar
PubMed
Search for other papers by Xiao Yu in
Google Scholar
PubMed
European Pancreas Center, Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany
Search for other papers by Yongchao Yang in
Google Scholar
PubMed
Introduction The incidence of pancreatic neuroendocrine neoplasm (pNEN), the most aggressive neuroendocrine malignancy among gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), has increased significantly over the past few decades
Search for other papers by Simon Schimmack in
Google Scholar
PubMed
Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China
Department of Burns and Plastic Surgery, The Third Xiangya Hospital, Central South University, Changsha, China
Search for other papers by Yongchao Yang in
Google Scholar
PubMed
Search for other papers by Klaus Felix in
Google Scholar
PubMed
Search for other papers by Markus Herbst in
Google Scholar
PubMed
Search for other papers by Yixiong Li in
Google Scholar
PubMed
Search for other papers by Miriam Schenk in
Google Scholar
PubMed
Search for other papers by Frank Bergmann in
Google Scholar
PubMed
Search for other papers by Thilo Hackert in
Google Scholar
PubMed
Search for other papers by Oliver Strobel in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasm (pNEN), the most aggressive neuroendocrine malignancy, has an increasing incidence, with 3.2 cases per 1,000,000 inhabitants currently being diagnosed annually in the United States ( 1 , 2 , 3
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Xuefeng Xu in
Google Scholar
PubMed
Search for other papers by Hongyun Ma in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Dansong Wang in
Google Scholar
PubMed
Search for other papers by Tiantao Kuang in
Google Scholar
PubMed
Search for other papers by Wenchuan Wu in
Google Scholar
PubMed
Search for other papers by Bin Song in
Google Scholar
PubMed
Search for other papers by Gang Li in
Google Scholar
PubMed
Search for other papers by Gang Jin in
Google Scholar
PubMed
Search for other papers by Wenhui Lou in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasms (pNENs) are rare and heterogeneous neoplasms of the pancreas, which make up 1–5% of all pancreatic neoplasms ( 1 , 2 ). The incidence and prevalence of pNENs have been increasing significantly
Search for other papers by Qi Zhang in
Google Scholar
PubMed
Search for other papers by Hongshan Wang in
Google Scholar
PubMed
Search for other papers by Yanhong Xie in
Google Scholar
PubMed
Search for other papers by Suming Huang in
Google Scholar
PubMed
Search for other papers by Ke Chen in
Google Scholar
PubMed
Search for other papers by Botian Ye in
Google Scholar
PubMed
Search for other papers by Yupeng Yang in
Google Scholar
PubMed
Search for other papers by Jie Sun in
Google Scholar
PubMed
Search for other papers by Hongyong He in
Google Scholar
PubMed
Search for other papers by Fenglin Liu in
Google Scholar
PubMed
Search for other papers by Zhenbin Shen in
Google Scholar
PubMed
Search for other papers by Weidong Chen in
Google Scholar
PubMed
Search for other papers by Kuntang Shen in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Yihong Sun in
Google Scholar
PubMed
Consensus on the Pathological Diagnosis of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms Experts Group. Chinese consensus on the pathological diagnosis of G and pancreatic neuroendocrine neoplasms experts G . Chinese Journal of Pathology 2021
Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Search for other papers by Johan Botling in
Google Scholar
PubMed
Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Search for other papers by Barbro Eriksson in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Search for other papers by Anders Sundin in
Google Scholar
PubMed
Search for other papers by Joakim Crona in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasms (panNENs) constitute a heterogeneous group of different diseases, in terms of biology as well as in patient characteristics and outcomes. The panNENs displaying the highest proliferation rate
Search for other papers by Chao-bin He in
Google Scholar
PubMed
Search for other papers by Yu Zhang in
Google Scholar
PubMed
Search for other papers by Zhi-yuan Cai in
Google Scholar
PubMed
Search for other papers by Xiao-jun Lin in
Google Scholar
PubMed
patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005 . Archives of Surgery 2007 142 347 – 354 . ( https://doi.org/10.1001/archsurg.142.4.347 ) 10.1001/archsurg
Search for other papers by Hanbaro Kim in
Google Scholar
PubMed
Search for other papers by Ki Byung Song in
Google Scholar
PubMed
Search for other papers by Dae Wook Hwang in
Google Scholar
PubMed
Search for other papers by Jae Hoon Lee in
Google Scholar
PubMed
Search for other papers by Shadi Alshammary in
Google Scholar
PubMed
Search for other papers by Song Cheol Kim in
Google Scholar
PubMed
.1001/archsurg.138.4.427 ) 11 Vagefi PA Razo O Deshpande V McGrath DJ Lauwers GY Thayer SP Warshaw AL Fernandez-Del Castillo C . Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General
Search for other papers by Logan Mills in
Google Scholar
PubMed
Search for other papers by Panagiotis Drymousis in
Google Scholar
PubMed
Search for other papers by Yogesh Vashist in
Google Scholar
PubMed
Search for other papers by Christoph Burdelski in
Google Scholar
PubMed
Search for other papers by Andreas Prachalias in
Google Scholar
PubMed
Search for other papers by Parthi Srinivasan in
Google Scholar
PubMed
Search for other papers by Krishna Menon in
Google Scholar
PubMed
Search for other papers by Corina Cotoi in
Google Scholar
PubMed
Search for other papers by Saboor Khan in
Google Scholar
PubMed
Search for other papers by Judith Cave in
Google Scholar
PubMed
Search for other papers by Thomas Armstrong in
Google Scholar
PubMed
Search for other papers by Martin O Weickert in
Google Scholar
PubMed
Search for other papers by Jakob Izbicki in
Google Scholar
PubMed
Search for other papers by Joerg Schrader in
Google Scholar
PubMed
Search for other papers by Andreja Frilling in
Google Scholar
PubMed
Search for other papers by John K Ramage in
Google Scholar
PubMed
Search for other papers by Raj Srirajaskanthan in
Google Scholar
PubMed
-functional tumours observed for a period of three years. The second study ASPEN (a prospective evaluation of the management of sporadic asymptomatic non-functioning pancreatic neuroendocrine neoplasms ≤2 cm) is a prospective observational study assessing time to
Search for other papers by Giulia Bresciani in
Google Scholar
PubMed
Search for other papers by Angeliki Ditsiou in
Google Scholar
PubMed
Search for other papers by Chiara Cilibrasi in
Google Scholar
PubMed
Search for other papers by Viviana Vella in
Google Scholar
PubMed
Search for other papers by Federico Rea in
Google Scholar
PubMed
Search for other papers by Marco Schiavon in
Google Scholar
PubMed
Search for other papers by Narciso Giorgio Cavallesco in
Google Scholar
PubMed
Search for other papers by Georgios Giamas in
Google Scholar
PubMed
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Search for other papers by Teresa Gagliano in
Google Scholar
PubMed
multi-tyrosine kinase growth factor receptor (RTKs) inhibitor indicated for the treatment of several NENs, such as gastrointestinal stromal tumours, advanced renal cell carcinoma and pancreatic neuroendocrine neoplasms ( 23 ). Its efficacy has been well